CATALENT XPRESS PHARMACEUTICS Trademark

Trademark Overview


On Monday, September 19, 2022, a trademark application was filed for CATALENT XPRESS PHARMACEUTICS with the United States Patent and Trademark Office. The USPTO has given the CATALENT XPRESS PHARMACEUTICS trademark a serial number of 97596774. The federal status of this trademark filing is REGISTERED as of Tuesday, March 21, 2023. This trademark is owned by CATALENT PHARMA SOLUTIONS, INC.. The CATALENT XPRESS PHARMACEUTICS trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; Manufacturing process consulting

Pharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of oral drug formulations and drug dosage for clinical studies; Scientific and technological services, namely, scientific research, analysis, and clinical testing in the field of pharmaceuticals, biopharmaceuticals, oral drug formulations and drug dosage; Scientific research and development; Consulting services for others in the field of designing clinical trials
catalent xpress pharmaceutics

General Information


Serial Number97596774
Word MarkCATALENT XPRESS PHARMACEUTICS
Filing DateMonday, September 19, 2022
Status700 - REGISTERED
Status DateTuesday, March 21, 2023
Registration Number7006423
Registration DateTuesday, March 21, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; Manufacturing process consulting
NOT AVAILABLE"EXPRESS PHARMACEUTICS"
Goods and ServicesPharmaceutical drug development services; Pharmaceutical research and development; Research and development in the field of oral drug formulations and drug dosage for clinical studies; Scientific and technological services, namely, scientific research, analysis, and clinical testing in the field of pharmaceuticals, biopharmaceuticals, oral drug formulations and drug dosage; Scientific research and development; Consulting services for others in the field of designing clinical trials

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code040
First Use Anywhere DateTuesday, January 18, 2022
First Use In Commerce DateTuesday, January 18, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 4, 2022
Primary Code042
First Use Anywhere DateTuesday, January 18, 2022
First Use In Commerce DateTuesday, January 18, 2022

Trademark Owner History


Party NameR.P. SCHERER TECHNOLOGIES, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSOMERSET, NJ 08873

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events


Event DateEvent Description
Tuesday, October 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 22, 2022NEW APPLICATION ENTERED
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Tuesday, November 22, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 22, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, November 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 22, 2022EXAMINER'S AMENDMENT ENTERED
Monday, November 28, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, November 28, 2022EXAMINERS AMENDMENT E-MAILED
Monday, November 28, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 28, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, November 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 18, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP